Candriam SCA’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,786
| Closed | -$2.4M | – | 899 |
|
|
2022
Q3 | $2.4M | Buy |
9,786
+7,438
| +317% | +$1.83M | 0.02% | 550 |
|
|
2022
Q2 | $581K | Buy |
2,348
+80
| +4% | +$19.8K | ﹤0.01% | 711 |
|
|
2022
Q1 | $751K | Buy |
+2,268
| New | +$751K | 0.01% | 700 |
|
|
2021
Q3 | – | Sell |
-764
| Closed | -$238K | – | 926 |
|
|
2021
Q2 | $238K | Sell |
764
-2,470
| -76% | -$769K | ﹤0.01% | 828 |
|
|
2021
Q1 | $1.01M | Hold |
3,234
| – | – | 0.01% | 634 |
|
|
2020
Q4 | $1.05M | Buy |
3,234
+898
| +38% | +$291K | 0.01% | 646 |
|
|
2020
Q3 | $647K | Sell |
2,336
-855
| -27% | -$237K | 0.01% | 684 |
|
|
2020
Q2 | $771K | Sell |
3,191
-561
| -15% | -$136K | 0.01% | 640 |
|
|
2020
Q1 | $626K | Hold |
3,752
| – | – | 0.01% | 697 |
|
|
2019
Q4 | $640K | Sell |
3,752
-2,330
| -38% | -$397K | 0.01% | 714 |
|
|
2019
Q3 | $1.08M | Buy |
6,082
+1,661
| +38% | +$295K | 0.01% | 594 |
|
|
2019
Q2 | $1.15M | Buy |
4,421
+660
| +18% | +$171K | 0.01% | 627 |
|
|
2019
Q1 | $1.07M | Buy |
3,761
+737
| +24% | +$210K | 0.01% | 614 |
|
|
2018
Q4 | $983K | Buy |
3,024
+184
| +6% | +$59.8K | 0.02% | 587 |
|
|
2018
Q3 | $1.28M | Buy |
2,840
+147
| +5% | +$66.1K | 0.02% | 581 |
|
|
2018
Q2 | $1.1M | Buy |
+2,693
| New | +$1.1M | 0.02% | 592 |
|